Therefore, it is suggested disrupting the activation of NF-κB, which leads to the transcription of multiple pro-inflammatory cytokines, including TNF-α and IL-1β, we can hope to reduce the inflammatory process in patients with HF. This evidence concerns the gene TNF and hydrops fetalis.